$PSID has been developing a real-time, point-of-care technology called FireflyDx that diagnoses diseases using a wide variety of sample types and requires as little as 10 minutes for sample preparation time. GenomeWeb Breaking News: PositiveIDs (PSID) ExcitePCR Subsidiary Aims to Launch Two Versions of POC MDx Platform Over Next Two Years https://ih.advfn.com/p.php?pid=nmona&article=75679141
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.